Scroll To Top

No Surprise Here: Newer Drugs Last Longer

No Surprise Here: Newer Drugs Last Longer


A new analysis in the journal AIDS has reached a conclusion few will find unexpected -- newer, once-daily, fixed-dose antiretroviral regimens like Epzicom, Atripla, and Truvada are more durable than earlier antiretroviral treatment options. 'Our results indicate this [improved durability is] due to both more convenient dosing and improved tolerability of modern antiretroviral regimens,' they conclude. Prolonging the durability of antiretroviral regimens is critical to achieving long-term treatment success since the medications must be taken indefinitely, the study authors say.

Advocate Channel - The Pride StoreOut / Advocate Magazine - Fellow Travelers & Jamie Lee Curtis

From our Sponsors

Most Popular

Latest Stories

HIV Plus Editors